B. Riley Wealth Management’s PDL BioPharma, Inc. PDLI Stock Holding History

B. Riley Wealth Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-400	Closed	-$2K	–	1143
2015 Q1	$2K	Sell	400 -2,000	-83%	-$14.5K	﹤0.01%	985
2014 Q4	$18K	Hold	2,400	–	–	0.01%	618
2014 Q3	$17K	Buy	2,400 +86	+4%	+$798	0.01%	659
2014 Q2	$22K	Buy	2,314 +1,914	+479%	+$17.1K	0.01%	647
2014 Q1	$3K	Buy	+400	New	+$3.43K	﹤0.01%	989

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

B. Riley Wealth Management's PDLI Position: Q2 2015 in Review

B. Riley Wealth Management sold out of PDL BioPharma, Inc. (PDLI) in Q2 2015, closing a stake of 400 shares — an estimated $2K sold.

B. Riley Wealth Management first reported a position in PDLI in Q1 2014 and held it in 5 quarters. The position peaked at $22K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q2 2015.

B. Riley Wealth Management reported no remaining PDL BioPharma, Inc. position as of Q2 2015 after selling out during the quarter.
B. Riley Wealth Management sold 400 PDL BioPharma, Inc. shares in Q2 2015, an estimated $2K.
B. Riley Wealth Management first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 5 quarters.
B. Riley Wealth Management's PDL BioPharma, Inc. position peaked at $22K in Q2 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2015.

Based on B. Riley Wealth Management's 13F filing for Q2 2015, filed 14 Jul 2015.